| Financial Year |
March 31 2023 |
| Monetary Funds |
494,461,643.24 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
29,380,734.38 |
| Accounts Receivable |
2,449,205,331.44 |
| Advances to Suppliers |
64,332,097.82 |
| Other Receivables |
78,012,981.80 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
2,876,068.06 |
| Inventories |
150,673,352.10 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
178,996,350.65 |
| Total Current Assets |
3,445,435,082.62 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
1,311,850.56 |
| Long-term Equity Investment |
695,982,164.70 |
| Investment Properties |
-- |
| Fixed Assetes |
8,545,126,196.75 |
| Under-construction Projects |
2,297,315,065.29 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
90,802,354.60 |
| R&D expenses |
64,915,606.79 |
| Goodwill |
37,929,208.54 |
| Long-Term Deferred and Prepaid Expenses |
9,851,881.34 |
| Deferred Income Tax Assets |
140,657,085.57 |
| Other Non-Current Assets |
254,773,884.79 |
| Sub-Total of Non-Current Assets |
12,376,009,247.56 |
| Total Assets |
15,821,444,330.18 |
| Short-Term Loans |
590,526,558.18 |
| Trading Financial liabilities |
-- |
| Notes Payable |
8,955,942.37 |
| Accounts Payable |
1,069,028,120.50 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
24,668,798.14 |
| Taxes Payable |
37,640,625.81 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
817,724,565.91 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
390,888,749.00 |
| Other Current Liabilities |
3,668,071.27 |
| Sub-Total of Current Liabilities |
2,979,433,867.67 |
| Long-term Loans |
4,155,522,150.39 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
1,156,956,471.38 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
47,194,288.30 |
| Other Non-Current Liabilities |
60,879.46 |
| Sub-Total of Non-Current Liabilities |
5,695,518,599.18 |
| Total Liabilities |
8,674,952,466.85 |
| Paid-In Capital(Or Share Stock) |
3,787,878,787.00 |
| Capital Surplus |
1,061,502,821.19 |
| Surplus Reserve |
115,569,808.42 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,576,537,778.03 |
| Minority Stockholder's Interest |
596,506,958.38 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
6,549,984,904.95 |
| Owner's Equity（Stockholder's Equity） |
7,146,491,863.33 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
15,821,444,330.18 |
